Heightened Characterization of AAVs by SEC-MALS with XBridge Premier GTx BEH SEC 450 Å 2.5 μm Columns
Applications | 2023 | WatersInstrumentation
Adeno-associated viruses (AAVs) are central to modern gene therapies, requiring precise measurement of particle size, aggregation state, and genome packaging to ensure safety and efficacy. SEC-MALS offers direct, multiattribute data without reliance on calibration standards, making it indispensable for process development and regulatory submissions.
This study assessed XBridge Premier GTx BEH SEC 450 Å 2.5 µm columns for high-resolution size exclusion chromatography coupled to multiangle light scattering (SEC-MALS). Key aims included characterization of AAV2 and AAV9 serotypes, quantifying monomer, aggregates, and empty/full capsid ratios under various column formats.
Sample preparation involved standard proteins (BSA, bovine thyroglobulin) and purified AAV2/AAV9 capsids at defined concentrations and empty/full ratios. Chromatographic conditions were isocratic in 2× PBS at 0.20 mL/min, 30 °C column temperature, and sample cooled to 6 °C. Detection combined UV absorbance (280 nm), refractive index (RI), and MALS (18 angles) with QELS for hydrodynamic radius. Data processing used Empower Pro 3 and ASTRA 8 software.
SEC-MALS resolved AAV monomers, dimers, and higher aggregates with minimal MALS noise (<30 µV). AAV2 monomer eluted at 12.2 min with molar mass ~3.7 MDa (Rg 11.6 nm, Rh 13.9 nm), while dimers and trimers measured 6.4 MDa and 9.1 MDa respectively. BTG dimer overlapped the AAV monomer, illustrating MALS utility for accurate mass determination regardless of retention time. AAV9 showed increased aggregation compared to AAV2, with monomeric mass ~3.8 MDa and well-resolved dimer at 8.2 MDa. Column diameter comparison (4.6 mm vs 7.8 mm) revealed slightly improved resolution on the wider format.
Empty/full capsid mixtures coeluted but ASTRA deconvoluted protein and nucleic acid masses for linear empty/full ratio determination (R² 0.9998), confirming capability for genome titration without qPCR or ELISA.
XBridge Premier GTx BEH SEC 450 Å 2.5 µm columns deliver high-efficiency AAV separation and reliable multiangle light scattering for comprehensive size, mass, and empty/full ratio analysis. Both narrow and wide bore formats are effective, supporting streamlined characterization workflows critical for gene therapy development and regulatory compliance.
Consumables, LC columns, GPC/SEC
IndustriesPharma & Biopharma
ManufacturerWaters
Summary
Significance of the Topic
Adeno-associated viruses (AAVs) are central to modern gene therapies, requiring precise measurement of particle size, aggregation state, and genome packaging to ensure safety and efficacy. SEC-MALS offers direct, multiattribute data without reliance on calibration standards, making it indispensable for process development and regulatory submissions.
Objectives and Study Overview
This study assessed XBridge Premier GTx BEH SEC 450 Å 2.5 µm columns for high-resolution size exclusion chromatography coupled to multiangle light scattering (SEC-MALS). Key aims included characterization of AAV2 and AAV9 serotypes, quantifying monomer, aggregates, and empty/full capsid ratios under various column formats.
Methodology and Instrumentation
Sample preparation involved standard proteins (BSA, bovine thyroglobulin) and purified AAV2/AAV9 capsids at defined concentrations and empty/full ratios. Chromatographic conditions were isocratic in 2× PBS at 0.20 mL/min, 30 °C column temperature, and sample cooled to 6 °C. Detection combined UV absorbance (280 nm), refractive index (RI), and MALS (18 angles) with QELS for hydrodynamic radius. Data processing used Empower Pro 3 and ASTRA 8 software.
Instrumentation Used
- ACQUITY UPLC H-Class Bio system
- ACQUITY Tunable UV Detector (Titanium flow cell, 5 mm, 1500 nL)
- 2414 Refractive Index Detector
- WYATT DAWN™ MALS with QELS module
- Columns: XBridge Premier GTx BEH SEC 450 Å 2.5 µm (4.6×150 mm, 4.6×300 mm, 7.8×300 mm)
Main Results and Discussion
SEC-MALS resolved AAV monomers, dimers, and higher aggregates with minimal MALS noise (<30 µV). AAV2 monomer eluted at 12.2 min with molar mass ~3.7 MDa (Rg 11.6 nm, Rh 13.9 nm), while dimers and trimers measured 6.4 MDa and 9.1 MDa respectively. BTG dimer overlapped the AAV monomer, illustrating MALS utility for accurate mass determination regardless of retention time. AAV9 showed increased aggregation compared to AAV2, with monomeric mass ~3.8 MDa and well-resolved dimer at 8.2 MDa. Column diameter comparison (4.6 mm vs 7.8 mm) revealed slightly improved resolution on the wider format.
Empty/full capsid mixtures coeluted but ASTRA deconvoluted protein and nucleic acid masses for linear empty/full ratio determination (R² 0.9998), confirming capability for genome titration without qPCR or ELISA.
Benefits and Practical Applications
- Optimized pore size (450 Å) and 2.5 µm packing for AAV fractionation
- Low MALS noise and high sensitivity for low-volume samples
- Robust separation of monomers vs aggregates for accurate quantitation
- Simultaneous determination of molar mass, size, and empty/full capsid ratio
Future Trends and Applications
- Integration of high-throughput SEC-MALS workflows for process monitoring
- Extension to additional viral vectors and biotherapeutic assemblies
- Real-time feedback loops in manufacturing via inline MALS detectors
- Advanced software analytics for automated multiattribute profiling
Conclusion
XBridge Premier GTx BEH SEC 450 Å 2.5 µm columns deliver high-efficiency AAV separation and reliable multiangle light scattering for comprehensive size, mass, and empty/full ratio analysis. Both narrow and wide bore formats are effective, supporting streamlined characterization workflows critical for gene therapy development and regulatory compliance.
References
- Fekete S., et al. Chromatographic Strategies for the Analytical Characterization of Adeno-Associated Virus Vector-Based Gene Therapy Products. TrAC Trends Anal. Chem. 2023;164:117088.
- DelveInsight Blog. AAV Vectors in Gene Therapy: How Recent Clinical Advances are Unraveling New Potentials? 2022.
- Nature Biotechnology. High-dose AAV gene therapy deaths. 2020;38(8):910.
- Pradhan S., et al. Viral Aggregation: The Knowns and Unknowns. Viruses. 2022;14(2).
- McIntosh NL., et al. Comprehensive Characterization and Quantification of Adeno Associated Vectors by Size Exclusion Chromatography and Multi Angle Light Scattering. Sci. Rep. 2021;11(1):3012.
- Wyatt Technology. AN7301: Online MALS-QELS (Quasi-Elastic Light Scattering).
- Wyatt Technology. AN1617: Quantifying quality attributes of AAV gene therapy vectors by SEC-UV-MALS-dRI.
- Tande BM., et al. Viscosimetric, Hydrodynamic, and Conformational Properties of Dendrimers and Dendrons. Macromolecules. 2001;34(24):8580–8585.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
Enhanced SEC-MALS analysis of therapeutic mAbs, biosimilars and AAVs with XBridge Premier columns
|Waters|Technical notes
W H I T E PA P E R WP1618: Enhanced SEC-MALS analysis of therapeutic mAbs, biosimilars and AAVs with XBridge Premier columns Leo Liu, Ph.D., Waters | Wyatt Technology Summary SEC-MALS is widely used for the characterization of biopharmaceuticals.…
Key words
mals, malsaav, aavxbridge, xbridgepremier, premiersec, secgtx, gtxaggregates, aggregatespertactin, pertactinmonomer, monomertherapy, therapycolumn, columnantibody, antibodygene, genebiosimilarity, biosimilarityattribute
Improved Size- Exclusion Chromatography of Adeno-Associated Viruses (AAVs) With XBridge Premier GTx BEH SEC 450 Å 2.5 μm Columns
2023|Waters|Applications
Application Note Improved SizeExclusion Chromatography of Adeno-Associated Viruses (AAVs) With XBridge™ Premier GTx BEH™ SEC 450 Å 2.5 µm Columns Mateusz Imiolek, Szabolcs Fekete, Matthew A. Lauber Waters Corporation Abstract This application note discusses the use of XBridge™ Premier GTx…
Key words
gtx, gtxxbridge, xbridgeaavs, aavsadeno, adenoviruses, virusespremier, premierbeh, behexclusion, exclusionassociated, associatedsize, sizeimproved, improvedaav, aavchromatography, chromatographyparticles, particlessec
Characterizing AAVs
2023|Waters|Guides
CONSUMABLES GUIDE BOOK Characterizing AAVs Chromatographic methods to measure heterogeneity and critical quality attributes CONSUMABLES GUIDE BOOK A Changing Industry Attribute Testing The advent of FDA approved gene therapies brings An AAV vectored therapy contains multiple types of biomolecules compromised…
Key words
aav, aavprotein, proteintransgene, transgenecapsid, capsidbook, bookpak, pakaex, aexencapsidation, encapsidationgenome, genomecolumn, columnpotency, potencyrplc, rplcdiameter, diameterpeptide, peptideconsumables
Size-Exclusion Chromatography Analysis of Adeno-Associated Virus (AAV) Preparations Using a 450 Å Diol-Bonded BEH Column and Fluorescence Detection
2020|Waters|Applications
[ APPLICATION NOTE ] Size-Exclusion Chromatography Analysis of Adeno-Associated Virus (AAV) Preparations Using a 450 Å Diol-Bonded BEH Column and Fluorescence Detection Stephan M. Koza and Weibin Chen Waters Corporation, Milford, MA, USA APPLICATION BENEFITS ■ ■ Optimization of SEC…
Key words
aav, aavadeno, adenoflr, flrvirus, virushmws, hmwsacquity, acquityassociated, associatedsec, secexclusion, exclusionpreparations, preparationsthyroglo, thyroglochromatography, chromatographylmws, lmwsuplc, uplcsize